Pitaric Capsule (Pitavastatin Calcium, Fenofibrate)

Adult dose

As a recommended dosage, take 1 capsule once daily, regardless of meals.

This medication may affect muscles, leading to symptoms such as myalgia or muscle weakness. In particular, there is a risk of serious side effects such as rhabdomyolysis, which can cause rapid muscle damage. Therefore, if symptoms such as muscle pain, tenderness, muscle weakness, or cramps occur during treatment, it is essential to consult a physician immediately. This medication should not be used in patients with poor kidney function, and caution is required for patients with mildly impaired renal function. Additionally, patients with liver dysfunction or a history of liver disease should consult their physician before taking this medication. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication, and it is not approved for use in children due to lack of safety data. The risk of muscle-related side effects may increase when this medication is used in combination with other lipid-lowering agents, so it should only be taken as directed by a physician. Regular blood tests to monitor liver function, kidney function, and indicators of muscle damage should be conducted before and during treatment. If any abnormal findings are noted, treatment may need to be discontinued immediately. It is advisable to avoid alcohol consumption during treatment, and caution should be exercised in patients with hypothyroidism, alcoholism, the elderly, and those with diabetes. Symptoms such as dizziness or headache may occur during treatment, so caution is advised when driving or operating machinery. Rarely, side effects such as skin rash, itching, severe skin reactions, blood dyscrasias, and gastrointestinal disturbances may occur, so any unusual symptoms should be reported to healthcare professionals immediately. In case of overdose, there is no specific antidote, and appropriate treatment and supportive care should be based on symptoms. This medication should be kept out of reach of children and stored in its original container to prevent misuse or degradation of quality.

Serious side effects

Urticaria, angioedema, chest discomfort, renal failure, rhabdomyolysis, severe skin reactions (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), jaundice, sudden and severe headache, paralysis, visual disturbances, thromboembolic events (pulmonary embolism, deep vein thrombosis), hypertension, interstitial lung disease, seizures, confusion, difficulty breathing, dyspnea, elevated blood pressure, severe edema, hematuria, significant decrease in urine output, renal impairment

Mild side effects

Nasopharyngitis, upper respiratory infection, dizziness, headache, heaviness in the head, stiffness, drowsiness, insomnia, paresthesia, thirst, dyspepsia, constipation, nausea, gastrointestinal discomfort, diarrhea, abdominal pain, taste disturbance, hair loss, malaise, skin pain, burning sensation, joint pain, edema, blurred vision, photophobia, hearing loss, hematuria, increased uric acid levels, increased serum potassium and phosphorus, abnormal blood tests (decreased hemoglobin, decreased white blood cell count, decreased platelet count, decreased granulocyte count)

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

It is a hard capsule with a dark green upper part and a white lower part, containing white round film-coated tablets and white rectangular enteric-coated film-coated tablets.

Package unit

30 capsules/box [10 capsules/PTP*3]